Further to intimation dated 17th November 2025, Sanofi India has informed that the remote e-voting for the Postal Ballot to seek the Members' approval for the appointment of Deepak Arora (DIN: 07495638) as a Director and Managing Director of the Company, has concluded. Accordingly, in compliance with Regulation 44 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, it has enclosed the Voting Results on the business transacted through the Postal Ballot Notice dated 27th October 2025 along with the consolidated Scrutinizer's Report on the remote e-voting and Postal Ballot, issued by Gaurav Sainani (ACS 36600, CP 24482), Partner at SGGS & Associates, Practicing Company Secretaries.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1668.00 |
| Dr. Reddys Lab | 1232.25 |
| Cipla | 1228.90 |
| Zydus Lifesciences | 936.35 |
| Lupin | 2328.60 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: